Dianthus Therapeutics (DNTH) Capital Expenditures (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Capital Expenditures came in at $5000.0 in Q3 2025, down 80.0% year-on-year from $25000.0 in Q3 2024, and down 89.13% quarter-over-quarter from $46000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Capital Expenditures (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Capital Expenditures history runs 9 years deep, the most recent figure standing at $5000.0 for Q3 2025.
- On a quarterly basis, Capital Expenditures fell 80.0% year-over-year to $5000.0 in Q3 2025; TTM through Sep 2025 was $106000.0, a 26.19% increase from a year earlier, with the FY2024 full-year figure at $105000.0, down 4.55% from the prior year.
- Capital Expenditures retreated to $5000.0 in Q3 2025 per DNTH's latest filing, from $46000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.1 million in Q3 2021 and bottomed at -$46000.0 in Q3 2022.
- The 5-year median for Capital Expenditures is $25000.0 (2024), against an average of $89105.3.
- Across the five-year window, Capital Expenditures jumped 5555.0% in 2021 and slumped 104.07% in 2022, its largest moves.
- Year by year, Capital Expenditures stood at $15000.0 in 2021, then jumped by 93.33% to $29000.0 in 2022, then slumped by 65.52% to $10000.0 in 2023, then jumped by 210.0% to $31000.0 in 2024, then sank by 83.87% to $5000.0 in 2025.
- Per Business Quant, the three latest DNTH Capital Expenditures figures stand at $5000.0 (Q3 2025), $46000.0 (Q2 2025), and $24000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |